The Iowa Supreme Court ruled that a country club and steakhouse could not recover losses they suffered due to the COVID-19 pandemic through insurance.
The inability of Wakonda Club and Jesse's Embers to properly utilize their properties when the state banned social meetings and in-person dining in 2020 did not trigger coverage under their property insurance policies, according to Iowa's highest court.
Wakonda Club's policy was issued by a unit of Selective Insurance Group Inc, and Jesse's Embers' policy was issued by Farm Bureau Financial Services.
Both businesses sought coverage after Iowa Governor Kim Reynolds issued a proclamation on March 2020 closing all bars and restaurants from dine-in or in-person service. In May 2020, it restarted limited, restricted in-person operations.
Wakonda Club claimed it was entitled to coverage under an all-risk commercial property insurance policy because the governor's proclamation amounted to a "direct physical loss of or damage to property," but Selective refused the claim.
But Justice Dana Oxley, writing for the 7-0 court, agreed Selective was off the hook, saying that Iowa law requires there to be a "physical aspect" to the loss of use of the property to satisfy the requirement of the club's policy.
Governor Reynolds' declaration, according to Oxley, was prompted by efforts to limit the spread of the COVID-19 virus, not because facilities like Wakonda Club were in imminent danger of physical violence that would result in property loss.
The verdicts were the latest in a string of setbacks for businesses around the country, which had filed hundreds of lawsuits demanding billions of dollars in compensation after governments enforced lockdowns and social gathering restrictions to slow the virus's spread.
The majority of such decisions were made by federal courts interpreting state statutes.
The ruling came after the Massachusetts Supreme Judicial Court determined in a similar case that the damages of three restaurants did not qualify as property losses needing compensation.


Eli Lilly and Novo Nordisk Battle for India’s Fast-Growing Obesity Drug Market
India–U.S. Interim Trade Pact Cuts Auto Tariffs but Leaves Tesla Out
Amazon Stock Rebounds After Earnings as $200B Capex Plan Sparks AI Spending Debate
CK Hutchison Unit Launches Arbitration Against Panama Over Port Concessions Ruling
Vanda Pharmaceuticals Wins FDA Approval for New Motion Sickness Drug After Four Decades
US Judge Rejects $2.36B Penalty Bid Against Google in Privacy Data Case
Anta Sports Expands Global Footprint With Strategic Puma Stake
Innovent Biologics Shares Rally on New Eli Lilly Oncology and Immunology Deal
American Airlines CEO to Meet Pilots Union Amid Storm Response and Financial Concerns
SpaceX Prioritizes Moon Mission Before Mars as Starship Development Accelerates
Sanofi Gains China Approval for Myqorzo and Redemplo, Strengthening Rare Disease Portfolio
Norway Opens Corruption Probe Into Former PM and Nobel Committee Chair Thorbjoern Jagland Over Epstein Links
Trump Backs Nexstar–Tegna Merger Amid Shifting U.S. Media Landscape
Taiwan Says Moving 40% of Semiconductor Production to the U.S. Is Impossible
TrumpRx.gov Highlights GLP-1 Drug Discounts but Offers Limited Savings for Most Americans
Australian Household Spending Dips in December as RBA Tightens Policy
SoftBank Shares Slide After Arm Earnings Miss Fuels Tech Stock Sell-Off 



